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cate that 76.19% of children allocated to the treatment group 
definitively no longer fulfilled DSM-IV criteria for SAD at fol-
low-up, compared to 13.64% in the waiting list group. Be-
tween 91 and 100% of children rated themselves or were 
rated by their father, mother or therapist as very much or 
much improved on the global success rating immediately 
after treatment. Results indicated large time by treatment 
condition interaction effect sizes (d = 0.98–1.41) across infor-
mants for reduction of distress/avoidance in separation situ-
ations after the test for the treatment condition. Further, par-
ents reported significant improvements in impairment/dis-
tress in the child’s major life domains and the child’s quality 
of life. Treatment gains were maintained at the 4-week fol-
low-up assessment.  Conclusions: Results indicate the short-
term efficacy of a disorder-specific treatment approach for 
SAD, and are among the first to indicate that CBT programs 
work with young children. 
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 Abstract 
 Background: Separation anxiety disorder (SAD) is one of the 
earliest and most common mental disorders in childhood, 
and a strong predictor of adult psychopathology. Despite 
significant progress in psychotherapy research on childhood 
anxiety disorders, no randomized controlled trial has been 
conducted with a disorder-specific treatment program for 
young children suffering from SAD.  Methods: Forty-three 
children (ages 5–7) with SAD and their parents were assigned 
to either a 16-session disorder-specific SAD treatment pro-
gram including parent training and classical cognitive-be-
havioral therapy (CBT) components, or to a 12-week waiting 
list group. Categorical and/or continuous data for anxiety, 
impairment/distress and quality of life were collected at 
baseline, after treatment/waiting list condition, and at a 
4-week follow-up.  Results: Intention-to-treat analyses indi-
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Introduction
 Separation anxiety disorder (SAD) is the earliest and 
one of the most common anxiety disorders in childhood 
 [1, 2] , and is the only childhood anxiety disorder for 
which specific diagnostic criteria have been formulated 
in the DSM-IV  [3] . SAD typically causes substantial im-
pairment in kindergarten/school, family relationships, 
and social functioning  [4] . Perhaps even more important-
ly, SAD is a significant risk factor for adult anxiety disor-
ders, including panic disorder, depression and substance 
abuse disorders  [5, 6] . Indeed, in one study, 73.5% of chil-
dren and adolescents with an SAD diagnosis developed 
an episode of psychopathology in young adulthood  [6] . 
Despite its early onset, high prevalence and unfavorable 
long-term prognosis, the treatment of SAD in young chil-
dren remains significantly underresearched, although it 
is likely that effective early treatment could favorably al-
ter the developmental course for children suffering from 
SAD, reducing not only current impairment, but the in-
cidence of mental disorder in adolescence and adulthood 
as well.
 Research on psychotherapy for childhood anxiety 
disorders has advanced considerably in recent years.
Meta-analyses and reviews indicate that cognitive-be-
havioral therapy (CBT) can be considered an evidence-
based psychotherapeutic technique for the treatment of 
anxiety disorders, with 68.9% of children completing 
CBT no longer meeting diagnostic criteria for their prin-
cipal pretreatment anxiety disorder, on average, com-
pared to only 12.9% of children assigned to a waiting list 
 [7, 8] . Intention-to-treat analyses indicate an average re-
mission rate for anxiety disorders of 56% after receiving 
CBT, versus 28.2–34.8% for controls  [7, 9, 10] . Overall, 
across studies examining the effects of CBT on anxiety, 
results indicate medium to large effects  [11] , with a mean 
pre/post-treatment effect size of 0.86 for treatment com-
pleters and moderate effects of 0.58 in intention-to-treat 
analyses  [7, 10] . The recently published pre/post-treat-
ment results of the Child/Adolescent Anxiety Multi-
modal Study, the largest randomized controlled trial 
(RCT) to date to assess treatment outcomes in children 
with anxiety disorders, comparing 4 treatment condi-
tions (CBT, SSRI medication, CBT + SSRI, and placebo), 
found short-term pre/post-treatment effect sizes of 0.31 
for CBT, 0.45 for SSRI, and 0.86 for CBT + SSRI (effect 
size not reported for placebo) for children aged 7–17 us-
ing the intention-to-treat sample  [12] . Finally, research 
indicates that CBT gains can be maintained up to sev-
eral years after treatment  [13] .
 In the treatment studies described above, however, 
treatment was administered to older children and adoles-
cents, with a mean age of 10.9 years (range 6–18) in the 
meta-analysis by In-Albon and Schneider  [7] , and a range 
of 7–17 years in Walkup et al.  [12] . In the review by James 
et al.  [10] , only 1 of the 13 studies reviewed included chil-
dren younger than 7 years (range 6–16), with a mean age 
of 9.66 years, i.e. still far from examining treatment ef-
fectiveness for very young children. Further, SAD is typ-
ically grouped together with generalized anxiety disor-
der, social phobia, and occasionally with specific phobias, 
using a single ‘global’ CBT program, based on the symp-
tom overlap and high comorbidity among anxiety disor-
ders. Until now, the efficacy of a disorder-specific treat-
ment, specifically tailored to the needs of young children 
with SAD, has remained untested. Research on adults in-
dicates that disorder-specific treatments for anxiety dis-
orders tend to produce higher effect sizes  [14] than those 
indicated to date for treatment of childhood anxiety dis-
orders  [7] and by the Child/Adolescent Anxiety Multi-
modal Study results (panic disorder/agoraphobia: 1.48, 
social phobia: 1.06, generalized anxiety disorder: 1.01) 
 [15] . While it is possible that psychotherapy simply works 
better for adults than for children, an alternative possibil-
ity is that the effect sizes are lower in children because 
child treatments have not been tailored to address spe-
cific anxiety disorders as they have for adults. Further, 
effect sizes for CBT with very young children are virtu-
ally unknown, given the dearth of studies for young chil-
dren. Initial evidence in favor of disorder-specific ap-
proaches for children comes from a meta-analysis on 
treatment studies for social phobia, indicating large pre/
post-treatment effect sizes of d = 1.02 for trait anxiety and 
d = 1.06 for social phobia symptoms  [16] .
 In the area of SAD, evidence from two small pilot stud-
ies is convincing  [17, 18] . Both treatments included parent 
training, targeting parent-child interactions and parent-
ing behavior. While Choate et al.  [17] trained parents ex-
clusively in behavior management skills and in the im-
provement of parent-child relationships, Eisen et al.  [18] 
included classical CBT ingredients such as psychoeduca-
tion, correction of dysfunctional cognitions in the child 
(mediated by the parent), exposure, and relapse preven-
tion, in addition to parent training. Both studies demon-
strated success. However, because of the pilot character of 
these studies (only 3–5 children, 4–10 years of age), these 
results await support from a larger sample using an RCT 
design.
 The present study reports on findings from our 
 treatment study, entitled ‘Trennungsangstprogramm für 
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Familien’ (TAFF; separation anxiety family therapy), 
which was specifically designed to address current gaps 
in psychotherapy and etiology research for children with 
SAD. The goals of the overarching study are twofold:
(1) to evaluate the short-term efficacy of a disorder-spe-
cific CBT program for SAD in young children using an 
RCT design and a multi-informant approach, and (2) to 
evaluate the long-term efficacy of the treatment of SAD 
in childhood in reducing the incidence of mental disor-
der in adolescence and young adulthood. The present re-
port provides an analysis of the short-term treatment ef-
fects in comparison to a waiting list condition, and on 
outcomes for both groups after treatment.
 Method 
 Study Design 
 The present study was conducted at our university outpatient 
clinic from December 2004 to January 2009, and was reviewed 
and approved by the local ethics committee for medical research. 
As no other therapy for young children with SAD has been evalu-
ated in an RCT to date, we tested the efficacy and safety of the new 
disorder-specific treatment against a waiting list group as a first 
step. The treatment condition included baseline assessment, 16 
sessions of disorder-specific CBT across 12 weeks, post-treatment 
questionnaire assessment and follow-up assessments at 4 weeks, 
12 months and 24 months. Data collection for the 1- and 2-year 
follow-up assessments is ongoing. Participants in the waiting list 
condition completed an initial baseline assessment, and were then 
placed on a 12-week waiting list before receiving treatment and 
participating in the 3 follow-ups. Diagnostic interviews were con-
ducted at baseline and at each follow-up. Self-report measures 
were administered at baseline, at every fourth therapy session, 
after the waiting list condition (waiting list group only), after 
treatment, and at each follow-up. To gain a thorough understand-
ing of the impact on diagnoses and mental health status, we used 
a multiple-informant approach, including reports from children, 
both parents, therapists, and blinded clinicians  [19] .
 Participants 
 Participants were recruited from local child and adolescent psy-
chiatrists, psychological therapists, pediatricians, and through 
newspaper advertisements and flyers. Inclusion criteria were a pri-
mary diagnosis of SAD according to the DSM-IV-TR  [20] , knowl-
edge of the local language, age between 5 and 7 years, written pa-
rental informed consent and verbal child assent to randomized as-
signment to either the immediate treatment condition or the 
waiting list condition, and completion of psychological assess-
ments. Children taking psychotropic medication were excluded. 
All participants received free diagnostic assessment and treatment.
 Figure 1 provides a participation flowchart in accordance with 
the CONSORT guidelines and checklist (online supplementary 
checklist, www.karger.com/doi/10.1159/000323444) adhered to 
throughout the study  [21, 22] . One hundred and twenty families 
contacted the department and underwent a telephone screening 
for participation in the present treatment study. Forty-three chil-
dren meeting DSM-IV-TR criteria for SAD and their parents (9 
boys and 13 girls in the waiting list condition, 9 boys and 12 girls 
in the treatment condition) met inclusion criteria for the present 
study and were randomly assigned to treatment or waiting list 
conditions. Randomization was conducted by a statistician using 
a computerized permuted block design, with assignments con-
cealed until the time of group assignment. Two families in the 
treatment condition declined to begin treatment or to participate 
in assessment beyond baseline. One child in the treatment and 1 
in the waiting list condition became inactive during treatment, 
and declined assessment beyond baseline. No known adverse 
events related to the treatment or study contributed to study with-
drawal. Four children in the waiting list condition no longer need-
ed treatment after the waiting period and thus did not receive 
treatment, but still participated in post-waiting list and follow-up 
assessment. Analyses include all available data on all children, 
and are considered intention-to-treat analyses, although post-
treatment data were not available for 3 children in the treatment 
condition and for 1 child in the waiting list condition. Further, 
mothers were required to participate, but not all fathers partici-
pated in all assessments (varies by assessment).
 Participant Demographics 
 The mean age of the children was 6.29 years (SD = 1.01) in the 
treatment group and 6.18 years (SD = 0.73) in the waiting list 
group with no between-group difference [t(41) = 0.09, p  1 0.05]. 
The mean age of mothers was 38.26 years (SD = 4.00) in the treat-
ment group and 36.66 years (SD = 4.43) in the waiting list group 
with no between-group difference [t(36) = 1.23, p  1 0.05]. The 
mean age of fathers was 41.09 years (SD = 5.07) in the treatment 
group and 39.37 years (SD = 5.12) in the waiting list group with 
no between-group difference [t(33) = 1.00, p  1 0.05]. Forty-two 
children (97.67%) were living with 1 or both biological parents, 
and 1 child from the waiting list group (2.33%) was adopted. 
Within the treatment group, 20 sets of parents were married or 
cohabiting, and 1 was divorced/single and within the waiting list 
group, 20 were married or cohabiting and 2 were divorced or sin-
gle with no between-group difference [  2 (1, n = 43) = 0.31, p  1 
0.05]. Parents’ education was indicated on a scale with the follow-
ing values: 1 (did not finish school), 2 (obligatory school, equiva-
lent to US 10th grade), 3 (vocational training), 4 (‘Matur’; slightly 
higher than a high school diploma), 5 (professional training), 6 
(university degree). Using this scale, mothers’ mean education 
was 3.85 (SD = 1.18) in the treatment group and 3.19 (SD = 0.75) 
in the waiting list group [t(39) = 2.14, p  ! 0.05]. Mothers’ educa-
tion was not correlated with any outcomes at the Bonferroni-cor-
rected 0.001 level, and thus was not considered to correlate more 
than would be expected by chance. Thus, mothers’ education was 
not controlled for in further analyses. Fathers’ mean education 
was  4.21  (SD  =  1.03)  in  the  treatment   group   and   4.50   (SD   = 
1.25) in the waiting list group with no between-group difference 
[t(35) = –0.77, p  1 0.05]. Thirteen treatment group mothers and 
10 waiting list mothers were working outside the home, and 7 
treatment group mothers and 12 waiting list group mothers were 
not, with no between-group difference [  2 (1, n = 42) = 1.62, p  1 
0.05]. Sixteen treatment group fathers and 19 waiting list group 
fathers were working outside the home, while 2 treatment group 
fathers and 2 waiting list group fathers were not, with no between-
group difference [  2 (1, n = 39) = 0.03, p  1 0.05]. On a scale rang-
ing from 1 (less than 2,000 CHF per month) to 6 (more than 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 8
:0
1:
39
 A
M
 CBT for Separation Anxiety Disorder Psychother Psychosom 2011;80:206–215 209
10,000 CHF per month), with 3 = 4,000–6,000 and 4 = 6,000–
8,000 CHF per month, the mean income was 4.15 (SD = 1.42) in 
the treatment group, and 3.61 in the waiting list group, with no 
between-group difference [t(36) = 1.03, p  1 0.05].
 Clinical Severity Rating and Comorbidity  
 Mean clinician-rated severity on a scale ranging from 1 (no 
impairment) to 8 (very severe impairment), with a rating of  6 4 
judged as clinically relevant for SAD, was 5.90 (SD = 0.91) in the 
treatment group, and 5.86 (SD = 1.32) in the waiting list group, 
with no significant between-group difference [t(40) = 0.10, p  1 
0.05]. Nine children (40.91%) in the waiting list condition, and 8 
children (38.10%) in the treatment condition presented with clin-
ically significant kindergarten/school reluctance [a score of ‘often’ 
or ‘very often’ on the school refusal item in the ‘Diagnostisches 
Interview bei psychischen Störungen, im Kindes- und Jugendal-
ter’ (Kinder-DIPS; diagnostic interview for mental disorders in 
children and adolescents)], with no between-group difference 
[  2 (1, n = 42) = 0.10, p  1 0.05]. Comorbid diagnoses were present 
in 44.18% of children in the whole sample. Eleven (52.38%) chil-
dren in the treatment group presented with comorbid disorders 
[7 with another anxiety disorder, 2 with a sleeping disorder, 1 with 
a behavior disorder (oppositional defiant disorder), and 1 with a 
tic disorder], as did 8 (36.36%) children in the waiting list condi-
tion [6 with another anxiety disorder, 1 with an affective disorder, 
1 with a sleeping disorder, 2 with a behavior disorder (1 attention 
deficit hyperactivity disorder, 1 oppositional defiant disorder), 
and 2 with an elimination disorder (some had multiple comorbid-
ity)]. No significant difference was found for the presence of co-
morbidity between groups [  2 (1, n = 43) = 1.12, p  1 0.05].
 Treatment Protocol 
 The TAFF treatment manual was developed for the purpose of 
this study and is available upon request from the first author. 
Treatment was divided into individual and family sessions. The 
first 4 weeks of treatment consisted of SAD-specific psychoeduca-
tion in 4 weekly 50-min sessions with the child alone and 4 week-
ly 50-min sessions with the parents alone. Age-appropriate materi-
als with pictorial illustrations were developed to educate the chil-
dren. Children learned about normal and pathological anxiety, 
including the frequency of anxiety disorders in children, how to 
identify anxiety through body signs, and the interplay between 
thoughts, feelings, and actions. They learned to use an anxiety 
thermometer to rate their own anxiety, and learned about the ha-
bituation process using visual charts and graphs. They identified 
their own fears and, together with the therapist, created a fear hi-
Excluded after phone screening:
44 declined to participate
6 did not meet inclusion criteria
Excluded after interview:
6 declined to participate
21 did not meet inclusion criteria
120 assessed
for eligibility
Enrollment
43
randomized
21 allocated to immediate intervention
and completed baseline measures
18 received allocated intervention
2 declined to participate before
treatment started
1 did not receive allocated
intervention due to study
declination during treatment
22 allocated to waiting list and
completed baseline measures
17 received allocated intervention
4 did not need treatment after
waiting list
1 did not receive allocated
intervention due to study
declination during treatment
Allocation
18 assessed after treatment with
questionnaires
18 assessed after 4-week follow-up
(1- and 2-year follow-up ongoing) with
questionnaires and interviews
22 assessed after waiting list condition
with questionnaires and interviews
17 assessed after treatment with
questionnaires
After
treatment
21 assessed at 4-week follow-up
(1- and 2-year follow-up ongoing) with
questionnaires and interviews
4-week
follow-up
21 analyzed Analysis 22 analyzed
 Fig. 1. Participation flowchart. 
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erarchy and goals that they wanted to work on in therapy. Finally, 
children learned about the role of dysfunctional beliefs in main-
taining anxiety, and learned how to change these beliefs via a ‘real-
ity check’. At the end of the 4 child sessions, the rationale for ex-
posure was discussed, and tasks were created for the child to over-
come during the exposure treatment. During the 4 parent sessions, 
parents received psychoeducation tailored to the child’s SAD 
symptomatology, as well as on the etiology of SAD and separation 
as a developmental task. They, too, learned about the frequency of 
anxiety disorders, and about the interplay between emotions, 
thoughts, and behaviors. Parents were trained to identify and cor-
rect any of their own dysfunctional cognitions concerning separa-
tion anxiety  [23] , and learned to recognize and reframe dysfunc-
tional beliefs about separation situations. They were also trained 
in appropriate parental behaviors during separation, and worked 
with the therapist to create goals for the exposure portion of the 
therapy. Finally, parents were given time to ask questions related 
to their own child’s behavior, and were given brief training in gen-
eral behavior management strategies. The second 8 weeks of treat-
ment consisted of weekly 50-min family sessions, each split into 
two parts: one with parents and child together, and a second with 
the parents only. During the first part of the family sessions, ex-
posure in vivo was planned and discussed, with the last session 
dedicated to relapse prevention. The first exposure was always car-
ried out with the therapist present and leading the exposure, with 
the parents observing. The second exposure was conducted by the 
parents themselves, with one parent leading (the parents took 
turns), and the therapist coaching. When an exposure was planned 
for a session, it was carried out within a few minutes of the start of 
the meeting, and sufficient time was always allowed for habitua-
tion to take place. After the first two exposures, further exposures 
were typically carried out by the parents outside of the therapy ses-
sion, although the therapist was present if necessary. The therapy 
session with both parents and child present was then used to pro-
cess the last exposure and to plan the next. The parent-only por-
tions of the family sessions involved intensive coaching, practicing 
of parental behavior prior to exposure, reframing irrational beliefs 
about separation and parental self-concept, parenting strategies, 
and introducing and practicing behavioral strategies to aid in de-
veloping children’s autonomy and coping behavior. Ten qualified 
CBT psychotherapists with training in the disorder-specific CBT 
program for SAD conducted the therapy sessions. Therapists were 
trained and supervised weekly by the first author. Each session was 
videotaped, with consent, for the purpose of analyzing treatment 
integrity.
 Measures 
 Clinical Diagnoses.  The Kinder-DIPS  [24] is a structured par-
ent interview designed to assess mental disorders in children ac-
cording to DSM-IV-TR criteria  [20] . Clinician-based ratings of 
symptom frequency are assessed on a 4-point scale from 0 (never/
seldom) to 3 (very often), with frequency ratings  6 2 judged as 
clinically relevant. Clinician-based ratings of the degree of dis-
tress and impairment (in home, school, friendship, and leisure 
domains) caused by the presenting symptoms for the child are 
provided on a 4-point scale from 0 (not at all) to 3 (very strong). 
Test-retest reliability (  = 0.85–0.94; all DSM-IV diagnoses) and 
validity in past research are good, as are interrater reliability esti-
mates for diagnoses of SAD (  = 0.85), overall diagnosis of an 
anxiety disorder (  = 0.85), and other axis I disorders (  = 0.85–
0.94)  [25] . Interviews were conducted by trained clinical psychol-
ogists or advanced masters students, blinded to group status at all 
evaluations. 
 Global Success . Global success rating (child, parent, and thera-
pist forms)  [26] is a measure of clients’ and therapists’ subjective 
assessment of the overall success of treatment. Post-treatment 
global change was rated on a scale ranging from 1 (very much 
worse) to 7 (very much improved), with 4 indicating no change. 
This and all subsequent child measures were read aloud to the 
children.
 Separation Anxiety.  Parents and children completed the child 
and parent versions of the 12-item disorder-specific Separation 
Anxiety Inventory for Children (SAI)  [27] to assess the degree of 
avoidance of separations in a variety of settings (e.g. ‘I avoid going 
to sleep alone’) using a 5-point scale ranging from 0 (never) to 4 
(always). The original 12-item SAI showed good reliability (inter-
nal consistency = 0.85; test-retest reliability = 0.84) and construct 
validity  [28] . In the present study, 1 item assessing experiences not 
typical for the present age group (e.g. sleep-away camp) was 
dropped. Reliability for the 11 items in the current clinical sample 
was   = 0.59 (children), 0.55 (mothers), and 0.67 (fathers).
 Distress and Impairment.  Parents and children completed a 
German-adapted version of the 3-item Sheehan Disability Scale 
(SDS)  [29, 30] to assess distress and functional impairment due to 
anxiety in school, family life, and social life by responding to 6 
items on a scale ranging from 0 (mild) to 3 (extreme). Adult clin-
ical research indicates high internal consistency (  = 0.89) and 
good construct validity  [31] . The present scale was adapted for use 
with children for this study, and a similar child adaptation has 
demonstrated good internal reliability and convergent and diver-
gent validity using a 3-item scale ranging from 1 to 10  [32] . Reli-
ability for the current sample was   = 0.60 for children, 0.78 for 
mothers, and 0.57 for fathers.
 Manifest Anxiety.  Parents and children completed the Ger-
man version of the Revised Children’s Manifest Anxiety Scale 
(RCMAS  [33, 34] ; RCMAS-P  [35, 36] ) to assess general manifesta-
tions of the child’s anxiety;   values for the total anxiety score 
summed across the 28 items = 0.83 (children), 0.88 (mothers), and 
0.84 (fathers).
 Quality of Life.  Parents and children completed the 9-item 
child and parent versions of the Inventory for the Assessment of 
Quality of Life in Children and Adolescents (IQL)  [37, 38] to as-
sesses quality of life (e.g. ‘How do you get along with your fami-
ly?’) on a scale ranging from 1 (very well) to 5 (very badly). Valid-
ity research indicates that the child and parent versions of the IQL 
discriminate between children receiving inpatient versus outpa-
tient psychiatric care  [38, 39] . Prior research in German-speaking 
school children yielded   values of 0.63 (for children aged 7 and 
above) and 0.76 (parents), and test-retest reliability r of 0.72 (chil-
dren) and 0.80 (parents)  [40] ; internal consistency was 0.60 (chil-
dren), 0.53 (mothers), and 0.48 (fathers).
 Treatment Integrity. All therapy sessions were videotaped for 
later coding of the therapists’ adherence to the treatment protocol. 
Videos from 10 randomly selected participants were each coded 
by 2 trained masters student assistants, using a standard coding 
checklist. Intraclass correlation coefficients (two-way random ef-
fects model with absolute agreement, average measure reliability) 
indicated that ratings were highly consistent for adherence to the 
treatment protocol (intraclass correlation for the average rating = 
0.86, p  ! 0.05).
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 Statistical Analyses 
 The primary outcome measures included SAD diagnosis 
based on clinical interview, global success ratings (administered 
only after treatment), and SAI ratings. Impairment and distress, 
as assessed by the SDS, were used as a global outcome measure. 
Secondary outcome measures included the RCMAS and IQL.
 Two separate models were calculated for each of the continu-
ous outcome variables assessed before and after treatment (i.e., 
SAI, SDS, RCMAS, and IQL). In the first model, the efficacy of the 
treatment relative to the waiting list condition between baseline 
and end of treatment/end of waiting list was analyzed using linear 
mixed models to utilize all existing data  [41] , with time and treat-
ment as fixed effects. In the second model, differences between 
post-treatment and 4-week follow-up scores were tested using the 
combined sample. Power analyses using G * Power 3  [42] indicated 
power (1 –   error probability) of 0.80 with p  ! 0.05 for meaning-
ful medium and large effect sizes of 0.44 and greater.
 Results 
 Treatment Integrity 
 Ratings of adherence to the treatment protocol (aver-
aged across raters) indicated that across sessions, thera-
pists implemented 78.43% (SD = 8.15%; range = 65–93%) 
of the critical elements required for each session.
 Group Differences on Pretreatment Measures 
 Means and standard deviations for child self-report 
and parent report of child symptoms and quality of life 
are presented in  table 1 . Two-tailed independent t tests, 
also in  table 1 , indicated one group difference on the pre-
treatment variables: mothers in the waiting list condition 
reported higher scores on the IQL (indicating lower qual-
ity of life) than mothers in the treatment condition (effect 
size d = 0.71). As the linear mixed models accounted for 
baseline scores, no additional adjustments to the models 
were necessary based on this difference.
 Treatment Efficacy: Primary Outcomes 
 SAD Diagnoses. Parent Kinder-DIPS interviews at the 
4-week follow-up assessment confirmed that 3 (13.64%) 
of the 22 children allocated to the waiting list condition 
were definitively free from the SAD diagnosis after the 
waiting list period. In contrast, 16 (76.19%) of the 21 chil-
dren allocated to the immediate treatment condition 
were definitively SAD free at the 4-week follow-up with a 
significant difference between the waiting list and treat-
ment conditions when using the 39 children for whom 
these data were available [  2 (1) = 21.59, p  ! 0.001, effect 
size Somers’ d = 0.74]. When assuming the 4 decliners 
retained SAD diagnoses at the 4-week follow-up (thus us-
Table 1.  Means and standard deviations by time and group, baseline group effects, and interaction effects
Baseline After waiting list/treatment Time ! condition 
effectswaiting list treatment waiting list treatment
n mean (SD) n mean (SD) t (d.f.) n mean (SD) n mean (SD) F (d.f .) d
Primary outcomes
Separation anxiety (SAI)
Child 17 1.97 (0.91) 14 2.13 (0.99) 0.48 (29) 17 1.65 (1.00) 14 0.87 (0.90) 5.88 (30.98)* 0.98
Mother 22 2.62 (0.73) 18 2.59 (0.76) –0.13 (38) 21 2.50 (0.74) 15 1.53 (0.69) 12.72 (37.34)** 1.31
Father 19 2.26 (0.76) 17 2.57 (0.83) 1.14 (34) 18 2.39 (0.75) 11 1.61 (0.69) 11.10 (31.45)** 1.41
Secondary outcomes
Impairment/distress (SDS)
Child 19 0.57 (0.41) 18 0.65 (0.59) 0.48 (35) 22 0.43 (0.64) 16 0.34 (0.41) 0.502 (37.49) 0.32
Mother 22 1.26 (0.60) 20 1.18 (0.51) –0.43 (40) 21 1.23 (0.69) 16 0.42 (0.32) 13.83 (38.34)** 1.30
Father 20 1.03 (0.49) 20 1.03 (0.43) 0.00 (38) 18 1.18 (0.61) 12 0.51 (0.31) 10.36 (36.15)** 1.34
Manifest anxiety (RCMAS)
Child 18 0.35 (0.22) 15 0.48 (0.19) 1.68 (31) 21 0.29 (0.22) 13 0.23 (0.20) 3.86 (33.16) 0.91
Mother 20 0.51 (0.20) 16 0.40 (0.25) –1.36 (34) 19 0.46 (0.21) 14 0.23 (0.19) 2.61 (31.62) 0.65
Father 18 0.45 (0.23) 15 0.38 (0.20) –0.94 (31) 17 0.40 (0.23) 10 0.22 (0.18) 7.59 (26.65)* 0.53
Quality of life (IQL)
Child 19 2.04 (0.73) 18 2.00 (0.51) –0.18 (35) 22 1.70 (0.61) 15 1.55 (0.57) 0.39 (36.09) 0.19
Mother 22 2.55 (0.47) 20 2.27 (0.30) –2.34 (40)* 21 2.51 (0.73) 16 1.69 (0.37) 10.89 (38.63)** 0.66
Father 20 2.34 (0.40) 20 2.21 (0.35) –1.03 (38) 18 2.26 (0.64) 11 1.73 (0.35) 7.52 (33.78)* 0.62
* p < 0.05; ** p < 0.01.
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ing the full n = 43 sample),   2 (1) = 17.05, p  ! 0.001, and 
effect size Somers’ d = 0.63. After both groups had com-
pleted treatment, 33 children (76.74%) definitively no lon-
ger met criteria for SAD, 4 children continued to meet 
criteria (9.30%), and data were unavailable for 6 children 
(13.95%) at the 4-week follow-up.
 Global Success Ratings.  Mean global success ratings 
from children who engaged in therapy are displayed in 
 table 2 for children, parents, and therapists at the end of 
treatment and at the 4-week follow-up. Mean ratings were 
between 6.19 and 6.69 across all raters and rating periods, 
with 88.57–100% of all raters indicating much to very 
much improvement both immediately after treatment 
and at the 4-week follow-up.
 Treatment by Time Effects on the SAI.  Table 1 displays 
the treatment (waiting list or immediate treatment) by 
time (before and after immediate treatment) interaction 
F    tests    and    effect    sizes.    Linear    mixed    models   indicat-
ed significant treatment by time interactions for child, 
mother and father reports of the level of child’s avoidance 
in separation situations.
 Maintenance    of    Effects    on    SAI    at    the    4-Week   Fol-
low-Up.  A repeated-measures ANOVA comparing child, 
mother, and father reports on the SAI, RCMAS, SDS, and 
IQL indicated a nonsignificant omnibus within-subject 
effect comparing end-of-treatment ratings to 4-week fol-
low-up ratings [F(2, 12) = 0.47, p  1 0.05]. However, be-
cause the listwise deletion inherent in ANOVA reduced 
the sample size for all measures due to missing data, 
paired t tests were also conducted.  Table 3 displays mean 
differences and t tests between the end of treatment and 
the 4-week follow-up. No significant differences were ob-
served between end-of-treatment and 4-week follow-up 
scores on the SAI.
 Treatment Efficacy: Secondary Outcomes 
 Treatment by Time Effects.  Linear mixed model analy-
ses ( table 1 ) indicated significant treatment by time inter-
actions for mother and father reports of distress/impair-
ment (SDS), and of quality of life and for father reports of 
manifest anxiety (RCMAS). There were no significant 
treatment by time interaction effects for child-reported 
impairment and distress (SDS), child and mother reports 
of general manifest anxiety (RCMAS), or child-reported 
quality of life (IQL). 
 Maintenance of Effects at the 4-Week Follow-Up.  Paired 
t tests ( table 3 ) did indicate one significant difference be-
tween end-of-treatment and 4-week follow-up scores on 
secondary outcome measures. Fathers reported an in-
crease in quality of life (IQL) at the 4-week follow-up 
(mean = 1.81, SD = 0.58) compared to the end of treat-
ment [mean = 1.64, SD = 0.42, t(16) = –2.40, p  ! 0.05, r = 
0.52].
Table 2.  Global success ratings
n Range Mean (SD) Reporting much 
to very much 
improved, %
After treatment
Child 35 2–7 6.46 (1.04) 91.43
Mother 33 6–7 6.61 (0.50) 100.00
Father 23 5–7 6.35 (0.57) 95.65
Therapist 35 5–7 6.43 (0.66) 91.43
4-week follow-up
Child 35 5–7 6.43 (0.70) 88.57
Mother 35 3–7 6.17 (0.82) 88.57
Father 25 5–7 6.24 (0.52) 96.00
Therapist 34 5–7 6.21 (0.59) 91.18
Table 3.  Paired differences between end of treatment and 4-week 
follow-up in the combined sample
Mean difference
(SD)
t (d.f.)
Primary outcomes
Separation anxiety (SAI)
Child –0.05 (0.88) –0.28 (27)
Mother –0.10 (0.50) –1.11 (27)
Father 0.03 (0.38) 0.36 (16)
Secondary outcomes
Impairment/distress (SDS)
Child –0.01 (0.37) –0.08 (30)
Mother 0.08 (0.41) 1.03 (28)
Father 0.08 (0.42) 0.81 (17)
General anxiety (RCMAS)
Child 0.03 (0.13) 1.34 (25)
Mother 0.03 (0.16) 0.91 (25)
Father –0.00 (0.14) –0.06 (15)
Quality of life (IQL)
Child –0.11 (0.38) –1.53 (29)
Mother –0.11 (0.44) –1.34 (28)
Father –0.17 (0.29) –2.40 (16)*
* 2-tailed p < 0.05.
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 Discussion 
 The present study is the first RCT of a disorder-specif-
ic CBT for SAD in young children, combining parent 
training, disorder-specific psychoeducation for children 
and parents, correction of disorder-specific dysfunction-
al cognition in both children and parents, and intensive 
exposure training in separation anxiety situations. Ad-
vantages of the present study are inclusion of more severe 
cases, such as those refusing to attend kindergarten or 
school, a group excluded in previous research  [12] , and 
the use of a multi-informant approach. As agreement be-
tween parents’ and children’s reports tends to be low  [43] , 
the generally consistent pattern of effects among raters in 
the present study is notable.
 Results show significant improvements across all pri-
mary outcome measures. Intention-to-treat analyses in-
dicate that at the 4-week follow-up, as compared to the 
post-waiting list time point, 76.19% of children allocated 
to the immediate treatment group (data not available for 
3 decliners) definitively no longer fulfilled DSM-IV cri-
teria for SAD according to parent interview, compared to 
13.64% in the waiting list group (no post-data for 1 de-
cliner). Eighty-eight to 100% of the child, father, mother 
and therapist global success ratings indicated much to 
very much improvement after treatment. Further, signif-
icant and large group by time interactions (d = 0.98–1.41) 
were observed in levels of mother-, father- and child-rat-
ed avoidance in separation situations (SAI) and mother- 
and father-rated impairment/distress (SDS) in important 
life domains. Significant medium effects (d = 0.62 and 
0.66) were observed in parent-rated quality of life (IQL). 
Further, all improvements were maintained at the 4-week 
follow-up assessment. Notably, the present values indi-
cate larger effects than those reported in prior meta-anal-
yses and reviews on the effectiveness of CBT for children 
with anxiety disorders  [7, 10] .
 Still, two results in particular warrant further discus-
sion. First, while both mothers and fathers reported sig-
nificant improvement in impairment/distress in major 
life domains, child ratings did not indicate significant 
improvement. An examination of child-reported base-
line values indicates that children reported little to no 
impairment or suffering at baseline, leaving little to no 
room for improvement. Such ratings may have been in-
fluenced by the parent-referred, and not child-referred, 
nature of the present sample. Further, as parents may ar-
range everyday life around the child’s separation anxiety, 
there may indeed be no distress or impairment for the 
child to perceive. Nonsignificant findings may also be re-
lated to the internal consistency of some measures, which 
was less than ideal. Second, the large effect size in separa-
tion anxiety ratings across all informants may not be di-
rectly comparable to the average effect sizes reported in 
existing meta-analyses, as these typically rely on trait 
anxiety measures rather than disorder-specific measure-
ments, perhaps leading to larger effect sizes. Still, the ef-
fect size of 0.91 for child-reported trait anxiety in the 
present intention-to-treat analyses is higher than the av-
erage effect size of 0.58 for child reports  [10] , and thus 
supports the hypothesis that a disorder-specific approach 
may improve the effects of CBT in children with anxiety.
 Limitations 
 Discerning the active ingredients responsible for treat-
ment success in the present multicomponent approach 
was not possible, as treatment success was compared to 
the waiting list condition (used as no known comparison 
treatments have been validated for very young children, 
and considered a first step). In addition, as there are no 
representative data on sociodemographic and clinical 
characteristics of children with SAD in the population 
from which the sample was taken, we are not able to judge 
the representativeness of the present sample. Also, the 
present study does not address long-term maintenance, 
although further follow-ups are underway. Finally, it is 
unclear whether this new program would be effective 
with older children. A study directly comparing the pres-
ent disorder-specific treatment program against a global 
treatment approach in older children is underway.
 Conclusion 
 The present study indicates the short-term efficacy of 
a disorder-specific treatment approach for SAD, as com-
pared to a waiting list, using parent training and classical 
CBT interventions specifically tailored to SAD. It is one 
of the first indicating that CBT programs can work with 
young children, and the first program specific to SAD. 
Follow-up assessments are expected to shed light on 
whether early successful treatment of SAD reduces not 
only immediate distress, but also the incidence of later 
mental disorders. Furthermore, our longitudinal data on 
the course of childhood SAD after treatment are expect-
ed to inform the field regarding the etiology of mental 
disorders in adulthood, as we follow up the children in 
the program and observe whether the incidence of adult 
disorder is reduced in comparison to existing studies on 
the outcomes of childhood anxiety disorders.
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